[{"address1": "Fitzwilliam Court", "address2": "1st Floor Leeson Close", "city": "Dublin", "zip": "D02 YW24", "country": "Ireland", "phone": "353 1 669 4820", "website": "https://www.iterumtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Corey N. Fishman", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1298811, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Judith M. Matthews", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 747774, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael W. Dunne M.D.", "age": 63, "title": "Strategic Advisor & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 115000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Loughman Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Barrett", "title": "Senior Vice President of Legal Affairs & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven I. Aronin M.D.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.2, "open": 1.23, "dayLow": 1.08, "dayHigh": 1.26, "regularMarketPreviousClose": 1.2, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.08, "regularMarketDayHigh": 1.26, "beta": 2.28, "forwardPE": -1.1336634, "volume": 269452, "regularMarketVolume": 269452, "averageVolume": 138884, "averageVolume10days": 116310, "averageDailyVolume10Day": 116310, "bid": 1.11, "ask": 1.16, "bidSize": 100, "askSize": 100, "marketCap": 18955360, "fiftyTwoWeekLow": 0.622, "fiftyTwoWeekHigh": 2.5, "fiftyDayAverage": 1.4019, "twoHundredDayAverage": 1.38979, "currency": "USD", "enterpriseValue": 21295344, "floatShares": 16235045, "sharesOutstanding": 16554900, "sharesShort": 1265223, "sharesShortPriorMonth": 1246632, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0764, "heldPercentInsiders": 0.01454, "heldPercentInstitutions": 0.056479998, "shortRatio": 9.58, "shortPercentOfFloat": 0.0779, "impliedSharesOutstanding": 16830800, "bookValue": -0.373, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -35583000, "trailingEps": -2.64, "forwardEps": -1.01, "lastSplitFactor": "1:15", "lastSplitDate": 1660780800, "enterpriseToEbitda": -0.486, "52WeekChange": 0.040909052, "SandP52WeekChange": 0.22553468, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ITRM", "underlyingSymbol": "ITRM", "shortName": "Iterum Therapeutics plc", "longName": "Iterum Therapeutics plc", "firstTradeDateEpochUtc": 1527255000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2a47ad90-f2ae-3045-b6c4-2f53ded8d73b", "messageBoardId": "finmb_318354064", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.145, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 18214000, "totalCashPerShare": 1.1, "ebitda": -43780000, "totalDebt": 20554000, "quickRatio": 1.025, "currentRatio": 1.071, "returnOnAssets": -0.72514, "returnOnEquity": -5.5568, "freeCashflow": -26696876, "operatingCashflow": -42823000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-30"}]